Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families
Guardant HealthGuardant Health(US:GH) Businesswire·2026-01-08 13:05

Core Insights - Guardant Health, Inc. announced that its Shield blood test for colorectal cancer screening is now covered for active-duty service members and their families through TRICARE, with no copay for average-risk individuals aged 45 and older [1] Company Overview - Guardant Health is a leading precision oncology company focused on innovative cancer screening solutions [1] Product Details - The Shield blood test is the first and only blood test approved by the FDA as a primary screening option for colorectal cancer [1]

Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - Reportify